Navigation Links
Stereotaxis Procedure Prominently Featured on BBC Documentary 'From the Heart'
Date:2/17/2010

ST. LOUIS, Feb. 17 /PRNewswire-FirstCall/ -- Stereotaxis (Nasdaq: STXS) announced that the recent BBC documentary "From the Heart" included a cardiac ablation procedure performed with the Stereotaxis System by Dr. Muchtiar Khan of OLVG Hospital in Amsterdam.  The program's second half, beginning at 10:30 of the 25-minute run time, features extensive scenes from the Stereotaxis procedure.  The documentary highlights how treatment of complex left atrial arrhythmias can reduce the growing prevalence of stroke. The documentary portrays Stereotaxis as an  effective alternative to anti-arrhythmic drugs, and includes a visually compelling demonstration of the system's precise control of a magnetic catheter.  The documentary is available at http://bit.ly/9e3C5P.

According to the documentary, fifteen percent of strokes are caused by atrial fibrillation, which affects over 6 million people world-wide and will increase approximately 2.5-fold by the year 2050.  The program emphasizes how tens of thousands of people can be saved from stroke by identifying and treating patients with arrhythmia.

The Stereotaxis system allows the physician to control the tip of the catheter by using magnetic fields, providing reduced radiation exposure, a low major adverse event rate and clinical results which mimic the best hands in the world.

For more information on Stereotaxis, please visit www.stereotaxis.com.

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. Stereotaxis' Odyssey workstation integrates and standardizes data through a consolidated display of multiple systems, eliminating the challenge of interacting simultaneously with many separate diagnostic systems. The magnetic irrigated catheter is not approved for the treatment of atrial fibrillation in the US. The core components of the Stereotaxis system have received regulatory clearance in the U.S., Europe and Canada.

SOURCE Stereotaxis

RELATED LINKS
http://www.stereotaxis.com/

'/>"/>

SOURCE Stereotaxis
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Stereotaxis Highlights New Data on Acute Success in AFib Treatments With Niobe Magnetic Navigation System
2. Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System
3. Stereotaxis Highlights Live Coronary and Peripheral Vascular Cases Performed at TCT With Stereotaxis Magnetic Navigation System
4. Stereotaxis Provides Fourth Quarter 2007 Revenue Outlook
5. Stereotaxis Receives $20 Million in Additional Loan Commitments
6. Stereotaxis to Present at the Deutsche Bank Small- and Mid-Cap Growth Conference
7. Stereotaxis Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call
8. Stereotaxis Appoints Senior Vice President of Global Marketing and General Manager for Europe
9. Stereotaxis Niobe Magnetic Navigation Systems Perform Approximately 15,000 Cases
10. Stereotaxis to Present at the Deutsche Bank 33rd Annual Health Care Conference
11. Stereotaxis Reports Record First Quarter Orders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Public relations ... and across a variety of business channels. , While many results are clear, much ... public relations program. , When it comes to measurement, firms should always take ...
(Date:3/28/2017)... ... , ... With expansion and efficiency in mind, Patten Seed Company completed relocation ... plant opened in Marshallville in 2006, and a bagging and shipping facility has been ... of Patten Seed operations to the Middle Georgia location from their previous home in ...
(Date:3/28/2017)... ... ... common and unwelcomed occurrence in people of all ages, genders and ethnicities. Dermatologist Dr. Sonoa ... dealing with excess skin oil. “Oily skin is a challenge to many of my patients. ... oily shine while keeping the skin fresh and clean,” says Dr. Au. , What causes ...
(Date:3/28/2017)... ... March 28, 2017 , ... Nurse ... profession as their value increases in the healthcare workforce, according to a survey ... job boards, career fairs, and candidate leads to healthcare employers of physicians and ...
(Date:3/28/2017)... ... 28, 2017 , ... Bacteria and fungi are probably not the first ingredients that come to ... the right microorganisms in your diet can actually improve health outcomes. And the good news ... the topic of a new peer-reviewed paper led by Maria Marco, Ph.D. ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TEL AVIV, Israel , March 28, 2017 ... Israel . This new business entity, Emosis Ltd, headquartered in ... research and development of novel assays complementing the mother company existing ... locally support commercialization and sales development of Emosis kits. ... This strategic move starts building ...
(Date:3/28/2017)... 2017 The global surgical ... value of USD 4.5 billion by 2025, according to ... closure of injured tissues post operation is a major ... occur in 3% to 15% of cases and are ... one third of postoperative deaths in patients. Surgical sealants ...
(Date:3/27/2017)... , March 27, 2017 ... better understand Bayer and its partnering interests and activities since ... report provides an in-depth insight into the partnering activity of ... On demand company reports are prepared upon purchase to ensure ... data. The report will be delivered in PDF ...
Breaking Medicine Technology: